Page1of2January21,2013
InstitutionalReviewBoard
OfficeofResearchCo m plia nce
NewStudyReviewChecklist
V.1
NEWSTUDYFULLBOARDREVIEWCHECKLIST
Directions:Thepurposeofthischecklististoprovidedocumentationofdeterminingwhetheraprojectmeetsthe
criteriaforapprovalataconvenedfullboardmeeting.PleasecontacttheIRBstaffifyouareunabletoreviewthis
studyorhaveaconflictofinterestrelatedtothisresearchor
review.
I.GENERAL
ProjectTitle:
PrincipalInvestigator:
MUIRB#:HR
Reviewer:
ForMeetingDate:
II.REVIEWCRITERIA:
1. Allappropriatedocumentsareincludedforreview.
YES
NO NA
2. Riskstoparticipants areminimizedbyusingprocedureswhichareconsistent
withsoundresearchdesignanddonotunnecessarilyexposeparticipantstorisk.
YES
NO NA
3. Riskstoparticipants areminimizedwheneverappropriate,byusingprocedures
alreadybeingperformedontheparticipantsfordiagnosticortreatment
purposes.
YES NO NA
4. Riskstoparticipants arereasonableinrelationtoanticipatedbenefits,ifany,to
participants,andtheimportanceoftheknowledgethatmayreasonablybe
expectedtoresult.
YES NO NA
5. Selectionofparticipantsisequitabletakingintoaccountthepurposesofthe
research,thesettinginwhichtheresearchwillbeconducted,thespecial
problemsofresearchinvolvingvulnerablepopulations,theselectio ncriteriaand
therecruitmentprocedures.
YES NO NA
6. Informedconsentwillbesoughtandappropriatelydocumentedfromeach
prospectivesubjectorthesubject’slegallyauthorizedrepresentative.Ifawaiver
toobtain,documentoraltertherequir ementsofinformedconsentisbeing
requested,thereisadequatejustificatio ntodoso.
YES NO NA
7. Whenappropriate,theresearchplanmakesadequateprovisionformonitoring
thedatacollectedtoensurethesafetyofparticipants .
YES NO NA
8. Whenappropriate,thereareadequateprovisionstoprotecttheprivacyof
participantsandtomaintaintheconfidentialityofdata.
YES NO NA
9. Areadequatesafeguardstillinplaceforparticipantswhoarelikelytobe
vulnerabletocoercionorundueinfluence?
YES NO NA
Page2of2January21,2013
10. Aretheresignificantnewfindingsconcerningthisres earchthatmightaffectthe
willingnessofparticipantstocontinuetotakepartintheresearch.Ifthereare
significantnewfindings,aretheyadequatelyconveyedtotheparticipants?
YES NO NA
11. Doanyreportsofnoncomplianceorparticipantcomplaintsrepresent
unanticipatedeventsorproblemsinvolvingriskstoparticipantsorothersor
seriousorcontinuingnoncompliance?
YES NO NA
III.EXPEDITEDCATEGORY9RECOMMENDATION
1. Researchpreviouslyreviewedandapprovedbythefullboardmaybeapproved
forfuturecontinuingreviewsunderexpeditedcategory9ifconditionsa,b,andc
aremet:
(a) Theresearchisnotconductedunderaninvestigationalnewdrugapplication
(IND)orinvestigationaldeviceexemption(IDE);and
(b) Noadditional
riskshavebeenidentifiedsinceIRBreviewataconvened
meeting;and
(c) TheIRBhasdeterminedanddocumentedataconvenedmeetingthatthe
researchinvolvesnogreaterthanminimalrisk.
Basedon(a)and(b),wouldyourecommendfuturecontinuingreviewsforthis
studyundercategory9?If
so,thecommitteewillberecommendedtovoteon
thisfor(c).
YES NO NA
IV.DETERMINATION
Recommendapprovalwithnochangesorstipulations
Recommenddisapprove
Recommendapprovalwithchangesorstipulations(usecomment boxbelow)
COMMENTS